AU7782091A - Creación de Inventos y Patentes con Inteligencia Artificial

AU7782091A – A process for distinguishing nucleic acids on the basis of nucleotide differences
– Google Patents

AU7782091A – A process for distinguishing nucleic acids on the basis of nucleotide differences
– Google Patents
A process for distinguishing nucleic acids on the basis of nucleotide differences

Info

Publication number
AU7782091A

AU7782091A
AU77820/91A
AU7782091A
AU7782091A
AU 7782091 A
AU7782091 A
AU 7782091A
AU 77820/91 A
AU77820/91 A
AU 77820/91A
AU 7782091 A
AU7782091 A
AU 7782091A
AU 7782091 A
AU7782091 A
AU 7782091A
Authority
AU
Australia
Prior art keywords
primer
dna
nucleic acid
extension product
nucleic acids
Prior art date
1990-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU77820/91A
Other versions

AU639565B2
(en

Inventor
Kenneth James Livak
Jan Antoni Rafalski
Scott Valray Tingey
John Gregory Kelly Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

EIDP Inc

Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1990-03-14
Filing date
1991-02-12
Publication date
1991-10-10
Family has litigation

First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=23963743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7782091(A)
«Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-02-12
Application filed by EI Du Pont de Nemours and Co
filed
Critical
EI Du Pont de Nemours and Co

1991-10-10
Publication of AU7782091A
publication
Critical
patent/AU7782091A/en

1993-07-29
Application granted
granted
Critical

1993-07-29
Publication of AU639565B2
publication
Critical
patent/AU639565B2/en

2011-02-12
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions

C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

C12Q1/6844—Nucleic acid amplification reactions

C12Q1/6858—Allele-specific amplification

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC

Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

Y10T436/00—Chemistry: analytical and immunological testing

Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]

Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]

Y10T436/143333—Saccharide [e.g., DNA, etc.]

Abstract

A process is provided for detecting polymorphisms on the basis of nucleotide differences in random segments of the nucleic acid by performing a primer extension reaction on the nucleic acids and comparing the extension reaction products. The random nucleic acid segment can be amplified by first dissociating the extension product from the template and contacting the dissociated extension product with a primer under conditions such that an amplification extension product is synthesized using the dissociated extension product as a template. Differences in the extension product are useful as markers in constructing genetic maps and as markers to distinguish or identify individuals.

Description

HUE A PROCESS FOR DISTINGUISHING NUCLEIC ACIDS ON THE BASIS OF NUCLEOTIDE DIFFERENCES FIELD OF THE INVENTION
This invention relates to a process for distinguishing nucleic acids. More particularly, random nucleic acid segments are distinguished by comparing nucleotide differences in extension reaction products. BACKGROUND OF THE INVENTION
The science of genetics is based on the identification and characterization of mutations, which are changes in DNA (DNA polymorphisms) due to nucleotide substitution, insertion, or deletion. Many techniques have been developed to compare homologous segments of DNA to determine if the segments are identical or if they differ at one or more nucleotides. Practical applications of these techniques include genetic disease diagnoses, forensic techniques, human genome mapping and agricultural applications.
The most definitive method for comparing DNA segments is to determine the complete nucleotide sequence of each segment. Examples of how sequencing has been used to study mutations in human genes are included in the publications of Engelke et al., Proc. Natl . Acad. Sci . U.S.A., 85:.544-548 (1988) and Wong et-al., Nature 330:384-386 (1987). At the present time, it is not practical to use extensive sequencing to compare more than just a few DNA segments, because the effort required to determine, interpret, and compare sequence information is extensive.
For genetic mapping purposes, the most commonly used screen for DNA polymorphisms arising from mutation consists of digesting DNA with restriction endonucleases and analyzing the resulting fragments, as described by

Botstein et al., Am. J. Hum. Genet . , 32:314-331 (1980); White, et al., Sci . Am . , 258:40-48 (1988). Mutations that affect the recognition sequence of the endonuclease will preclude enzymatic cleavage at that site, thereby altering the cleavage pattern of the DNA. DNAs are compared by looking for differences in restriction fragment lengths. A major drawback to this method (known as restriction fragment length polymorphism mapping or RFLP mapping) is its inability to detect mutations that do not affect cleavage with a restriction endonuclease. Thus, many mutations are missed with this method. One study by Jeffreys, Cell, 18:1-18 (1979), was able to detect only 0.7% of the mutational variants estimated to be present in a 40,000 base pair region of human DNA. Another difficulty is that the methods used to detect restriction fragment length polymorphisms are very labor intensive, in particular, the techniques involved with Southern blot analysis.
The primer extension process described in Proudfoot et al., Science 209:1329-1336 (1980), has been widely used to study the structure of RNA and also has been used to characterize DNA, see, e.g., Engelke et al., Proc. Natl . Acad. Sci . U.S.A., 85:544-548 (1988). This process consists of hybridizing a labeled oligonucleotide primer to a template RNA or DNA and then using a DNA polymerase and deoxynucleoside triphosphates to extend the primer to the 5′ end of the template. The labeled primer extension product is then fractionated on the basis of size, usually by electrophoresis through a denaturing polyacrylamide gel. When used to compare homologous DNA segments, this process can detect differences due to nucleotide insertion or deletion. Because size is the sole criterion used to characterize the primer extension product, this method cannot detect differences due to nucleotide substitution.

Mullis et al., U.S. Patent No. 4,683,195, and Mullis, U.S. Patent No. 4,683,202 disclose polymerase chain reactions which can be used to amplify any specific segment of a nucleic acid. These analytical methods have been used to detect polymorphisms through amplification of selected target DNA segments from test genomes. A drawback to such methods is the requirement that a sufficient number of bases at both ends of the specific segment be known in sufficient detail so that two oligonucleotide primers can be designed which will hybridize to different strands of the target segment. It is labor intensive to obtain the necessary sequence information from target genomes in order to design the necessary primers. M. H. Skolnic and R. B. Wallace, Simultaneous Analysis of Multiple Polymorphic Loci Using Amplified Sequence Polymorphisms (ASPs) , Genomics 2:273- 278.
Amplification using oligonucleotides of random sequence is described in a theoretical approach for mapping a genome of a higher eukaryote in «Happy Mapping: a Proposal for Linkage Mapping the Human Genome,» P. H. Dear and P. R. Cook, Nucleic Acids Research, Vol. 17, No. 17, 6795-6807 (1989) . The authors propose to identify the relationship between 5,000 different DNA segments amplified from human genomic DNA by performing a polymerase chain reaction (PCR) with various pairwise combinations of arbitrary- sequence primers. The template DNA is isolated separately from single haploid cells of an individual organism. Their method suggests generating a map describing the physical location of DNA regions giving rise to the amplified products in an individual organism. This would be accomplished by identifying PCR products which co-amplify from the same piece of DNA, thus establishing their physical proximity. In Dear and

Cook’s method, polymorphisms would be excluded from the analysis. Their idea requires the identification of the same DNA segment in many different haploid cells, and polymorphisms defeat this requirement. Although efficient at describing the physical relationship between any two PCR products, happy mapping cannot describe the location of any genetic traits of interest. This can only be accomplished by correlating the segregation of a genetic trait with many different polymorphisms through a sexual cross between two individuals. The authors teach that primer pairs longer than 9-10 nucleotides are necessary as primer pairs of 9-10 nucleotides would prime inefficiently.
The present invention provides a process for the detection of genetic polymorphisms in random nonspecific nucleic acid segments. The process utilizes a reaction primed by an oligonucleotide(s) conveniently prepared with no knowledge of the base sequence of segments amplified. SUMMARY OF THE INVENTION
The present invention provides a process for distinguishing nucleic acids on the basis of nucleotide differences in random segments of the nucleic acid comprising: (a) separately performing an extension reaction on each of at least two nucleic acids, said reaction comprising:
(i) contacting the nucleic acids with at least one oligonucleotide primer of greater than 7 nucleotides under conditions such that for at least one nucleic acid and extension product of at least one primer is synthesized; and
(b) comparing the results of the separately performed extension reactions for differences.

In another aspect of this invention, after step (i) and before step (b) , there are provided the additional steps of (ii) dissociating the extension product from its complement; and (iii) amplifying the random nucleic acid segment by contacting the dissociated extension product with a primer of step (i) under conditions such that an amplification extension product is synthesized using the dissociated extension product as a template. In another aspect of this invention, a difference in the extension product is used as a marker to construct a genetic map, and to distinguish or identify individuals.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 illustrates a photograph of a gel comparing amplification products from DNA isolated from the soybeans Glyine max (Bonus) (odd-numbered lanes) and
Glycine soja (PI 81762) (even-numbered lanes) where oligonucleotide primers of a variety of sequences were employed. Figure 2 illustrates a photograph of a gel comparing amplification products, utilizing primer 10b, of 19 F2 progeny of a cross between Bonus and PI 81762. Figure 3 illustrates a photograph of a gel comparing amplification products from Bonus (odd- numbered lanes) and PI 81762 (even-numbered lanes) .
Primer AP8 and 10 other primers differing in a single nucleotide from AP8 were employed.
Figure 4 illustrates a photograph of a gel comparing amplification products employing a variety of primers on Zea mays (corn) , Gossypium hirsutum (cotton) ,
Sacchoromvces cerevisiae (yeast) and Arabidopsis. thaliana DNA.
Figure 5 illustrates a photograph of a gel demonstrating amplification by priming with primers of six to ten nucleotides in length.

Figure 6 illustrates a photograph of a gel comparing amplification products from six transformed Homo sapien (human) lymphoblasts.
Figure 7 illustrates densitometric scans demonstrating F2 individuals of a cross between Bonus and PI 81762 homozygous (2 copies) for a polymorphism (Panel A) , heterozygous for a polymorphism (Panel B) and homozygous (0 copies) for a polymorphism (Panel C) . DETAILED DESCRIPTION OF THE INVENTION The term «oligonucleotide» as used herein refers to a molecule comprised of two or more deoxyribonucleotides or ribonucleotides.
The term «primer» as used herein refers to an oligonucleotide of any arbitrary sequence whether occurring naturally as in a purified restriction digest or produced synthetically, which is capable of acting as a point of initiation of synthesis when placed under conditions in which synthesis of a primer extension product which is complementary to a nucleic acid strand is induced, i.e., in the presence of nucleotides and an agent for polymerization such as DNA polymerase and at a suitable temperature and pH. It is preferable that primers are sequences that do not form a secondary structure by base pairing with other copies of the primer or sequences that form a «hair pin» configuration. The sequence conveniently can be generated by computer or selected at random from a gene bank. The primer is preferably single stranded for maximum efficiency in amplification, but may alternatively be double stranded. If double stranded, the primer is first treated to separate its strands before being used to prepare extension products. Preferably, the primer is an oligodeoxyribonucleotide. The term «random nucleic acid segment» as used herein refers to any template, the segment of nucleic

acid to be addressed by the primer, of which no sequence information need be known prior to extension. Applicants have found that it is not required, with the process of this invention, that a sufficient number of bases at both ends of a template be known in sufficient detail so that primers can be designed which will hybridize to different strands of the template.
In the process of the present invention, at least one primer of greater than 7 nucleotides is provided. Primers with less than 7 nucleotides prime inefficiently. Primers can be synthesized by standard techniques known to those skilled in the art. In the preferred form of the invention, at least one primer of 9 to 10 nucleotides in length is employed. Conveniently, one primer is employed. At least one primer employed may be biotinylated. That is, the primer may be covalently linked to a biotin or an analog of biotin. The linking group employed should be chosen to permit extension under the conditions detailed herein.
The process of the present invention for distinguishing nucleic acids compares differences in products of an extension reaction(s) separately performed on at least two random segments of nucleic acids.
In the first step of the present process, an extension reaction is (a) separately performed on each of at least two nucleic acids by (i) contacting the nucleic acids with at least one oligonucleotide primer of greater than 7 nucleotides under conditions such that for at least one nucleic acid an extension product of at least one primer is synthesized which is complementary to the random nucleic acid segment. A preferred embodiment of this extension reaction exploits the ability of most DNA polymerases to perform primer

extension reactions. Execution of a primer extension reaction requires a nucleic acid substrate consisting of a primer hybridized to a template strand such that the 3′ end of the primer is recessed relative to the 5′ end of the template strand. As primer extension methods are most commonly practiced, the primer is DNA, the template strand is either DNA or RNA, and a DNA polymerase is used to extend the primer. The basic elements required for execution of primer extension reactions are reviewed in Mullis et al., U.S. Patent No. 4,683,195, and Mullis, U.S. Patent No. 4,683,202.
The nucleic acids to be analyzed by this process may be DNA or RNA, and the DNA or RNA may be double stranded or single stranded. Any source of nucleic acid, in purified or nonpurified form, can be utilized as the starting nucleic acid. For example the nucleic acid may be from a natural DNA or RNA from any source, including virus, bacteria, and higher organisms such as plants, animals and microbes or from cloned DNA or RNA. Additionally, the nucleic acid may constitute the entire nucleic acid or may be a fraction of a complex mixture of nucleic acids. Preferably the nucleic acid is deoxyribonucleic acid. Surprisingly, Applicants have found the process of the present invention useful in distinguishing nucleic acids from different individual organisms containing small genomic DNA such as yeast DNA (2 x 107 base pairs per genome) as well as different individual organisms containing large genomic DNA such as human DNA (3.0 x 109 base pairs per genome) . The choice of nucleic acid polymerase used in the extension reaction, depends on the nature of the template. For DNA template strands, suitable commercially available DNA polymerase includes DNA polymerase obtained from the thermophilic bacterium Thermus aquaticus (Taq polymerase) or other thermostable

polymerases. Structural variants and modified forms of this and other DNA polymerases would also be expected to be useful in the process of the present invention. For RNA templates, reverse transcriptase is an example of a DNA polymerase that would also be expected to be useful. In the presence of the nucleoside triphosphate substrates, natural or analogues, the polymerase extends the length of the primer in the 3′ direction. The sequence of the extension product will generally be complementary to the corresponding sequence of the template strand.
The nucleoside triphosphate substrates are employed as described in PCR Protocols, A Guide to Methods and Applications, M. A. Innis, D. H. Gelfand, J.-J. Sninsky and T. J. White, eds. pp. 3-12, Academic Press (1989), which is incorporated by reference, and U.S. Patents 4,683,195 and 4,683,204. The substrates can be modified for a variety of experimental purposes in ways known to those skilled in the art. As an example, at least one of the natural nucleoside triphosphate substrates may be replaced by a mobility-shifting analogue as taught in U.S. Patent No. 4,879,214 which patent is incorporated by reference.
In another aspect of this invention, after step (i) is performed, the additional steps of (ii) dissociating the extension product from its complement; and (iii) amplifying the random nucleic acid segment by contacting the dissociated extension product with a primer of step (i) under conditions such that an amplification extension product is synthesized using the dissociated extension product as a template are performed.
An amplification reaction is generally described in Mullis et al., U.S. Patent 4,683,195 and Mullis, U.S. Patent 4,683,202, which patents are incorporated by reference. Specific conditions for amplifying a nucleic

acid template are described in M. A. Innis and D. H. Gelfand, PCR Protocols, A Guide to Methods and Applications, M. A. Innis, D. H. Gelfand, J.-J. Sninsky and T. J. White, eds. pp. 3-12, Academic Press (1989), which is incorporated by reference.
Specifically, Mullis is directed to a process for amplifying any desired specific nucleic acid sequence contained in a nucleic acid or mixture thereof. The process of Mullis comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, and extending the primers to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence. The primers of Mullis are designed to be sufficiently complementary to different strands of each specific sequence to be amplified. The steps of the reaction may be carried out stepwise or simultaneously and can be repeated as often as desired. In the extension reactions of the present invention, a nucleic acid is contacted with at least one oligonucleotide primer as described herein. The extension product is dissociated from the complementary random nucleic acid on which it was synthesized to produce a single-stranded molecule; and the random nucleic acid segment is amplified by contacting the single-stranded extension product with a primer from above under conditions as for example disclosed in PCR Protocols and U.S. Patent No. 4,683,202 such that an amplification extension product is synthesized using the single strand produced (i.e., the dissociated extension product) as a template.
The steps described herein may be conducted sequentially or simultaneously as taught by U.S. Patents 4,683,195 and 4,683,202. In addition, the steps may be repeated until the desired level of sequence

amplification is obtained as taught by U.S. Patents 4,683,195 and 4,683,202.
Following extension, the results of step (b) are compared for differences. Generally the results are products or an absence of product. Specifically, the products are compared to determine if the segments are identical or for differences in one or more nucleotides, by nucleotide substitution, insertion or deletion. Differences in the products can take the form of, for example, difference in size of each product, difference in the sequence of each product, difference in the quantity of each product produced, and differences in the number of products.
Comparison of the product can be accomplished by a variety of techniques known to those skilled in the art. Examples include nucleotide sequence determination of the amplified segment and RFLP analysis. Conveniently, comparison can be through a size fractionation medium. If the resolution of the size fractionation process is sufficient, differences of a single nucleotide can be detected. The preferred process for size fractionation is electrophoresis through a polyacrylamide or agarose gel matrix.
Simple inspection of the electrophoresis gel of the product can reveal polymorphisms that affect the size and quantity of the amplified segment and polymorphisms that determine whether a segment is amplified. Polymorphisms revealed by the present invention can be quantified by known densitometric procedures performed on the amplified product in the gel. Quantification is important in certain applications where it is necessary to distinguish homozygous from heterozygous polymorphisms. Applicants have found that a homozygote with two copies of the polymorphism generates twice as much of the product than does a heterozygote.

The process of the present invention has practical applications. Examples of such applications include genetic mapping and distinguishing and identifying individuals. Applicants have found that the polymorphisms or differences identified through the process of this invention can have utility in genetic mapping. Commonly, a genetic map is constructed by through RLFP analysis. A genetic map of an organism could be constructed, e.g. by substituting polymorphisms, identified using different primers on the same organism, detected by the present invention for the RFLPs used as genetic markers as described in the art, e.g., Botsein, D., «Construction of a Genetic Linkage Map in Man Using Restriction Fragment Length Polymorphisms»,
Am. J. Hum . Genet . 32:314-331, (1980) which reference is incorporated herein. Genetic mapping using the polymorphisms of the present invention as markers has important plant breeding applications as Applicants have determined that polymorphisms detected by the present invention are heritable genetic markers. These markers, just as RFLP markers in Tanksley, S. D., «RFLP Mapping in Plant Breeding: New Tools for an Old Science», Bio/Technology Vol. 7 March, 1989, pp.257-264, can be used as probes for the presence or absence of certain chromosome segments as Applicants have found that the polymorphisms detected by the process of the present invention can co-segregate with standard RFLP markers. Further, the process of the present invention can be used to construct a nucleic acid ‘fingerprint’. Such fingerprints are specific to individuals and can be applied to problems of identification or distinguishing of individuals. Such a ‘fingerprint’ would be constructed using multiple polymorphisms generated by different primers and detected by the present invention,

just as the polymorphisms are used to create a fingerprint in Jeffreys, A. J., «Individual-Specific ‘Fingerprints’ of Human DNA», Nature, Vol. 316 4 July, 1985 which reference is incorporated herein. That is, genomes are compared for the presence or absence of polymorphisms.
EXAMPLES
Example 1 demonstrates synthesis and purification of oligonucleotide primers. Example 2 shows that a variety of 10 nucleotide primers are able to amplify random nucleic acid segments, and that polymorphisms can be detected between genomic DNA samples from two soybean cultivars. Example 3 illustrates that polymorphisms revealed by this invention are inherited in normal fashion by the progeny of a cross between two soybean lines. This example establishes the utility of the polymorphisms as genetic markers. Example 4 shows that the pattern of amplified bands is specific to a given primer sequence. Most changes involving a single nucleotide in the primer sequence cause a complete alteration in the pattern of amplified DNA segments. This suggests that most single-nucleotide polymorphisms at corresponding priming sites in individual genomes will be seen by the process of the present invention as a difference in the pattern of amplified DNA segments. Example 5 illustrates that 10 nucleotide primers amplify generally equivalent numbers of DNA segments from both small and large genomes. Example 6 demonstrates the utility of primers of from 6 to 10 nucleotides in length. Example 8 shows the process of the present invention detects a polymorphism that can be used to distinguish human DNA samples. Example 9 shows quantitation of the amplification products.

EXAMPLE 1 Synthesis and purification of oligpnuclep-titie primers Eight oligonucleotide primers (Table I) were synthesized by standard solid-phase methods with phosphoramidite chemistry in a Du Pont Model Coder 300 automated DNA synthesizer (E. I. du Pont de Nemours and Company, Wilmington, DE) . The eight primers were of arbitrary nucleotide sequence. Each primer was selected to contain the same proportion of the bases A and T as the bases G and C for generally equal stability when attached to the template.
After deprotection in ammonium hydroxide according to standard practice, the samples were dried under vacuum, dissolved in 0.2 ml of TEN (10 mM Tris-Cl, pH 7.5, 1 mM NaEDTA, 10 mM NaCl) and purified by gel filtration chromatography on Sephadex G25 in NAP-5 cartridges (Pharmacia, Piscataway, N.J.) equilibrated in TEN. Gel filtration was accomplished by applying 0.2 ml of sample; followed by 0.6 ml of TEN, followed by 0.5 ml of TEN applied to the top of the column and collecting 0.5 ml of eluant. The concentration of purified oligonucleotide was calculated by absorbance at 260 nm on a spectrophotometer. An absorbance value of 1 corresponding to 33 μg/ml was assumed.
TABLE _I
Primer Primer Concentration of sequence name stock solution μσ
5′-AGCACTGTCA 10b 10
5′-TCGTAGCCAA AP3 10
5′-TCACGATGCA AP4 10 5′-CTGATGCTAC AP5 10

5′-GCAAGTAGCT AP6 10
5′-CTGATACGGA AP7 10
5′-TGGTCACTGA AP8 10
5′-ACGGTACACT AP9 10
EXAMPLE 2 Pr-jme-rs (Table I ) ςjete t polymorphisms in soybean DNA templates Genomic DNA was isolated from the soybean cultivars PI 81762 and Bonus by centrif gation in CsCl/ethidium bromide as described in Murray, M.G. «Rapid Isolation of High Molecular Weight Plant DNA», Nucleic Acids Res . Vol. 8 (1980) pp. 4321-4326 which reference is incorporated herei . The source of the soybean cultivars was Professor Theodore Hymowitz, University of Illinois.
Eight different oligonucleotides, each 10 nucleotides in length (Table I) were tested separately as primers in the amplification reaction detailed below for their ability to amplify DNA segments from the two varieties of soybean DNA.
The process of the present invention was performed in a reaction volume of 50 μl containing genomic DNA cocktails of 10 mM Tris-Cl, pH 8.3, 50 mM KC1, 2.5 mM MgCl2, 0.001% gelatin (Sigma, St. Louis, MO, cat. (1990) no. G-2500), 0.1 μg of soybean DNA, 20 pmole of oligonucleotide, 200 μM each of the deoxynucleotide triphosphates dATP,„dCTP, dGTP, dTTP, and 1.25 units of Amplitaq DNA polymerase (Perkin-Elmer Cetus cat. no. N801-0060, Norwalk, CN) . The genomic DNA cocktail was prepared by mixing ingredients 1-5 (Table II) and heating this mixture at 99°C for 4 minutes in the heating block of a DNA thermal cycler. This mixture was then cooled to room temperature before the addition of ingredients 6 and 7 (Table II) .

Amplification was conducted in 0.6 ml microcentrifuge tubes (cat. no. 1048-00-0 from Robbins Scientific Corp., 1280 Space Park Way, Mtn. View, CA 94943 (1990)) and the reaction was initiated by adding 48 μl of a genomic DNA cocktail (Table II) to 2 μl of each primer from Table I and overlayed with 40 μl of mineral oil (Sigma cat. no. M3516) .
lABJiE. II
Volume
± Genomic DNA cocktails PI81762 μl Bonus A∑
1 Deionized water 309.0 308.0
2 lOx Buffer* 45.0 45.0
3 MgCl2,200 mM 2.2 2.2
4 PI 81762 DNA, 672 μg/ml 1.3 –
5 Bonus DNA, 448 μg/ml – 2.0
6 Mixture of dATP, dCTP, dGTP, 72.0 72.0
TTP, 1.25 mM each
7 Amplitaq polymerase, 2.2 2.2 5 units/μl
*10x Buffer consists of 100 mM TrisCl (pH 8.3), 500 mM KC1, 15 mM MgCl2 and 0.01% Gelatin as directed in Perkin-Elmer Cetus cat. no. N 801-0060 Amplitaq DNA polymerase.
Temperature cycling in the .amplification reaction was performed in a DNA Thermal Cycler (Perkin-Elmer Cetus, Norwalk, CN) for 30 cycles with parameters set at: hold 94°C for 1 min, hold 35°C for 30 sec, ramp to 72°C in 1:51 min, hold 72°C for 2 min.
Upon completion of the 16 separate amplification reactions performed above, 5 μl aliquots of each sample were analyzed by electrophoresis on a 1.4% agarose gel

at 8.5 volt/cm for 60 minutes. Electrophoresis was conducted according to standard practice as described in J. Sambrook, E. F. Fritsch and T. Maniatis, Molecular Cloning A Laboratory Manual, Cold Spring-Harbor Laboratory Press, pp. 6.3-6.19 (1989), which is incorporated by reference. The gel was stained with ethidium bromide and was photographed.
Polymorphisms, i.e., difference in the reaction product in the DNA patterns were evident for all primers except AP6 by comparing DNA bands amplified by a given primer from both Bonus and PI 81762 (Figure 1) . Figure 1 is a photograph of the stained electrophoresis gel. Lane 0 is a molecular weight standard. Odd numbered lanes are the Bonus DNA amplification products from the eight primers (Table I) and even numbered Lanes are the PI 81762 DNA amplification products from the primers. It can be seen from the figure that random nucleic acid segments can be distinguished on the bases of nucleotide differences. As an example, two bands denoted «A» and «B» amplified by primer 10b were seen in DNA from PI 81762 (lane 2) but not from Bonus (lane 1) .
EXAMPLE 3 Amplified polymorphisms are useful for σenetic mapping
To determine whether such polymorphisms as seen in Example 2 have utility in genetic mapping, the band A polymorphism detected with primer 10b (Figure 2) was mapped to the soybean genome. This was accomplished by scoring each of 66 segregating F2 individuals (T.
Hymowitz, U. of 111.), for their parental pattern of inheritance of the band A polymorphism and correlating this with segregation data from the same 66 individuals for 430 RFLP markers previously mapped to the soybean genome (J. A. Rafalski and S. V. Tingey, Abstract,

Genome Mapping and Sequencing, April 26-30, 1989) . Samples of the F genomic DNA were subjected to the process of the present invention with primer 10b under the conditions described in Example 2 and analyzed by electrophoresis in a 1.4% agarose gel. Lane 0 is a molecular weight standard, and the remaining lanes are the reaction products of the F individuals. Table 3 presents the parental pattern of inheritance for the primer 10b band A polymorphism. Since band A is amplified from PI81762 and not Bonus (Figure 2) , the presence of band A in a particular sample indicates that it received at least one copy of that DNA segment from PI81762. At first inspection it is difficult to distinguish between homozygotes that have received two copies of band A from PI81762 and heterozygotes that have received only one copy of band A from PI81762. Therefore this polymorphism is scored as a dominant marker (see legend to Table 3) . Individuals that do not contain band A have inherited this segment of the genome from Bonus.
In order to determine the position of the band A locus in the soybean genome it was necessary to correlate the inheritance of this locus with that of several RFLP markers previously mapped to the soybean genome (J. A. Rafalski and S. V. Tingey, Abstract,
Genome Mapping and Sequencing, April 26-30, 1989) . This genetic map (data not shown) was constructed by standard RFLP methodology from analysis of the segregation patterns of many RFLP markers in the same F2 population as used in this example (for standard RFLP mapping technology, see T. Helentjaris, M. Slocum, S. Wright, A. Schaefer and J. Nienhuis, 1986, Theor. Appl . Genet . , 22.:761-769 which reference is incorporated herein) . The basis for genetic mapping analysis is that markers located near to each other in the genome are inherited

together in the F2 progeny, while markers located farther apart are co-inherited less frequently. Segregation analysis and marker map positions were calculated using the MapMaker program, incorporated herein (E. S. Lander, P. Green, J. Abrahamson, A.
Barlow, J. F. Daly, S. E. Lincoln and L. Newburg, 1987, Genomics 1:174-181). The results indicate that the primer 10b band A polymorphism maps to linkage group 17 in between RFLP markers 249 and 7315 at a distance from each marker of 9.4 and 9.2 centimorgans, respectively. The probability that the band A polymorphism segregated purely by chance in the observed data was only 1 chance in 10″11-8 indicating the strength of this map position. This example demonstrates that polymorphisms as revealed by the present invention have utility as genetic markers.

TABLE III 2 Individuals Marker Name 1 2 4 5 6 7 8 9 12 13 14 15 16 17 18 19 20 21 22 23 25 26 27 28 29 30 31 33 34 35
RFLP Marker 249 B A H H H H A H B H H H A H H H A H A H m H A H A B A B A H
RFLP Marker 7315 B A H m H A H H B B H A H H H H A H H m H m m H A B A B H H Primer 10b Band A b A b m b b m b b b b A A A b b A b A m b m A b A b A b b b
2 Individuals Marker Name 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 5 54 55 56 57 58 59 61 62 63 64 65 68
RFLP Marker 249 H B a H A A m A B B H B H A B A H B H B A A B m m m m m m H
RFLP* Marker 7315 H B H H A A A A H H H B H H B H H B H H A A B H H A H A m H Primer 10b Band A b b b b A A A A b b b b b b b A b b b b A A b b b m m A m b o
2 Individuals Marker Name 70 71 72 73 74 75 76 77 78 80 82 83 84 85 86 88 90 91 96
RFLP Marker 249 A H B A A H B B H H A B A A B m m m m
RFLP Marker 7315 m A m m A m B B H H H H A A A m m B A Primer 10b Band A m m m m A m b b A b b b A A b m m b A

Legend for Table III DNA isolated from 88 F2 individuals segregating from a cross between Bonus and PI81762. The genotype of each individual at each of the above marker loci was determined by either RFLP analysis or by the process of this invention (see text) . Individual scores indicate the parental genotype of the marker locus. A score of «A» or «B» designates that the locus was inherited from Bonus or P181762, respectively. A score of «H» designates that the locus was inherited both from Bonus and PI81762. A score of «a» designates that the locus was either inherited only from Bonus or that it was inherited from both Bonus and PI81762. A score of «b» designates that the locus was either inherited from PI81762 or that it was inherited from both Bonus and PI81762. A score of «m» designates missing data.
EXAMPLE 4 The pattern of amplification products of DNA segments is sensitive to single-nucleotide changes in the primer sequence
A series of primers were synthesized based on the oligonucleotide primer AP8 of Example 2 (Table I) . Each variant differed from the canonical sequence at a single nucleotide, progressing stepwise through the primer sequence. Nucleotide composition in each variant was maintained at 50% A+T as in Example 2. In Table IV, the nucleotide site that differs from the canonical sequence is shown in lower-case type.
TABLE IV
Primer Primer Concentration of sequence name stock solution
5′-TGGTCACTGA AP8 (canonical) 10 μM
5 ‘-aGGTCACTGA AP8-a 10 μM

5′-TcGTCACTGA AP8-b 10 μM
5′-TGCTCACTGA AP8-C 10 μM
5′-TGGaCACTGA AP8-d 10 μM
5′-TGGTgACTGA AP8-e 10 μM 5′-TGGTCtCTGA AP8-f 10 μM
5′-TGGTCAgTGA AP8-g 10 μM
5′-TGGTCACaGA AP8-h 10 μM
5′-TGGTCACTcA AP8-i 10 μM
5′-TGGTCACTRGt AP8-J 10 μM
Cocktails containing genomic DNA from Bonus and PI 81762 were prepared as described in Example 2 (Table II) . However, instead of using microcentrifuge tubes as the reaction vessels for amplification, the samples were placed in the wells of a polyvinyl chloride (PVC)
96-well microtiter plate (Falcon, 1989, 3911, Becton Dickinson Labware, Oxnard, CA) and were overlaid with 40 μl of mineral oil (Sigma, St. Louis, MO, cat. no. M3516 1990) . Unused wells were filled with 50 μl of water plus 40 μl of oil. The 96-well plate was placed without a lid in an air-driven cycling oven (BSC 1000 with temperature probe BSC-2005, Bios Corp., 291 Whitney Ave., New Haven, CT 06511) atop a metal test tube rack with a 1-inch square grid. The rack was made 2″ high by clipping the top tier from a three-tiered rack (4.75″ wide x 11.5″ long x 4″ high) . The freed tier was laid on top of the 96-well plate. The oven was in a room at an ambient temperature of 22°C and was programmed for 35 cycles with the parameters: hold 93°C for 1 min, hold 35°C for 1 min, ramp to 72°C in 2 min, hold 72°C for 2 min. The soak tolerance was set at 2°C.
After the amplification reaction of the present invention was complete, 12 μl of each sample was analyzed by electrophoresis on a 1.4% agarose gel as described in Example 2.

Figure 3 is a photograph of the stained electrophoresis gel. Lane 0 is a molecular weight standard. DNA amplification products are shown for Bonus (odd numbered lanes) and for PI 81762 (even numbered lanes) . Arrows mark the location in each primer that differs from the sequence of primer AP8. Each primer generated very different patterns of amplified DNA segments with the exception of AP8 and AP8-a which appeared to differ qualitatively in only 1 band (see 250 bp bands found only with AP8-a; Figure 3, lanes 1-4) . Whereas the overall pattern of bands differed for the majority of primers, there were at least some bands that may be common to different primers (note polymorphic 1 kb bands that appear to be amplified by AP8, AP8-a and AP8-b; Figure 3, lanes 1-6) . Except for primers AP8 and AP8-a, different polymorphisms between Bonus and PI 81762 were revealed with each primer. Among the patterns generated by all 11 primers, there were about 22 distinct polymorphisms as defined by the presence of a band in one genome and its corresponding absence in the other genome.
A few exceptions notwithstanding, a single nucleotide change in a primer generally produced a significant change in the pattern of amplified bands and revealed new polymorphisms. This suggests that the conditions of this experiment are sufficiently stringent so as to require the participation of most, if not all, of the bases in a given primer.
EXAMPLE 5
Amplification of DNA from various species with 10 nucleotide primers of arbitrary sequence In this Example, genomic DNA was tested from cotton (line # 315, Coker Seed Co., Hartsville, S.C. 29550), yeast (line DBY931, E. I du Pont de Nemours & Co.,

Wilmington, DE) , Arabidopsis (line W5, see K. A. Feldman et al.. Science, (1989) 243:1351-1354) and corn (line B73 University of Illinois) . DNA samples were prepared by standard methods as follows: Gossypium hirsutum (cotton), R. Bernatzky and S. D. Tanksley 1986, Theor. Appl . Genet 72, 314-321; Sacchoromvces cerevjsjae (yeast), R. W. Davis, M.-Thomas, J. Cameron, T. P. St. John, S. Scherer and R.-A. Padget 1980, Methods Enzymol . 65, 404-411; Arabidopsis thaliana (Arabidopsis), Shure, Wessler, Fedoroff, 1983, Cell, 35, 225-233; and Zea mavs (corn), Dellaporta, S. L. «Molecular Biology of Plants a Laboratory Course Manual,» Cold Spring Harbor, N.Y., 11724 (1985), pp. 36-37. Reaction ingredients were used at the concentrations specified in Example 2, and were prepared as shown in Table V.
TABLE V
Cocktail Volume μl
Deionized water 1837.0 lOx Buffer 550.0
MgCl , 1 M 5.5
Mixture of dATP, dCTP, dGTP, 880.0
TTP, 1.25 mM each Amplitaq polymerase, 5 units/μl 27.0
Primers AP3, AP4r AP5, AP6, AP7 and AP8 (Table I) were diluted with water to concentrations of 2 μM. Genomic DNA samples were diluted with water to concentrations of 10 mg/ml, were heated at 99°C for 4 minutes in the Perkin-Elmer cycler, and cooled to room temperature prior to use. Reaction mixtures for amplification were prepared in a PVC 96-well plate by mixing 10 μl of genomic DNA, 10 μl of primer Table I,

and 30 μl of cocktail Table V. All sample wells were utilized and all were overlayed with a drop (40 μl) of mineral oil. Thermal cycling was in the cycling oven, as described in Example 4. Annealing temperature was programmed at 36°C.
Amplification reaction products were analyzed by agarose gel electrophoresis as in Example 3. Figure 4 illustrates a photograph of a stained electrophoresis gel. Lanes 1-6 are DNA amplification products from cotton, Lanes 7-12 from yeast, Lanes 13-18 from
Arabidopsis and Lanes 19-20 from corn. The results show that all of the genomic DNA samples were successfully amplified by most of the tested primers. This is surprising in view of the small genome sizes of yeast and arabidopsis relative to that of cotton, corn and soybean.
EXAMPLE 6 Primers greater than 7 nucleotides support DNA amplification
In this Example, six different primers between 6 and 10 nucleotides in length (Table VII) were compared for the ability to function as primers in the amplification reaction. Reaction ingredients were as described in Example 2 and were prepared as shown in Table VI.

TABLE VI
Genomic DNA Cocktail Volume m
Bonus P181762
Deionized water 1240 1242 lOx Buffer 175 175
MgCl2r 200 mM 3.5 3.5
Mixture of dATP, dCTP, d LGGTTPP,,
TTP, 1.25 mM each 140 140 Amplitaq polymerase, 5 uinniittss//μμll 9 9 Bonus DNA, 448 μg/ml 7.8 PI 81762 DNA, 670 μg/ml 7.8
TABLE VII
Primer Primer Cone, of
Sequence Name Stock Solution
5′-ATTGCGTCCA AP13 4 μM
5′-TTGCGTCCA AP13a 4 μM
5′-TGCGTCCA AP13b 4 μM
5′-GCGTCCA AP13c 4 μM
5*-CGTCCA AP13d 4 μM
5′-CGCCCA AP13e 4 μM
Primer AP13 was an arbitrary sequence of 50% A plus T as in Example 1. Primers AP13a through AP13e were designed by sequentially removing nucleotides from the 5’ end. Primer AP13c had an additional T substituted by a C to lend stability. Each primer (2.5 μl) was mixed separately in 0.6 ml microcentrif ge tubes as in Example 2 with 22.5 μl of each cocktail containing template DNA from either Bonus or PI 81762. Each mixture was overlayed with 40 μl of mineral oil (Example 2) . Temperature cycling was performed in a DNA Thermal Cycler (Perkin Elmer-Cetus,

Norwalk, CT) for 35 cycles with parameters set at: hold 94°C for 1 min, hold 35°C for 1 min, ramp to 72°C in 2 min, hold 72°C for 2 min. After the amplification reaction of the present invention was complete, 12 μl of each sample was analyzed by electrophoresis on a 1.4% agarose gel as described in Example 2.
Figure 5 is a photograph of a stained electrophoresis gel. Lane 0 is a molecular weight standard. The results indicate that under the chosen conditions of amplification, primers shorter than 8 nucleotides do not support detectable levels of amplification.
EXAMPLE 7 Amplification of human DNA with a 10 nucleotide primer of arbitrary sequence (AP9)
TABLE VIII
Cocktail Volume μl
Deionized water 103.5 lOx Buffer* 45.0
MgCl2, 50 mM 9.0
Mixture of dATP, dCTP, dGTP, 45.0 TTP, 2 mM each
AP9 primer, 10 μM 18.0
(see Example 2) AmpliTaq polymerase, 5 units/μl 4.5
*(The lOx Buffer used here consists of 100 mM
Tris-HCl, ph 8.3; 500 mM KC1; 15 mM MgCl2; 50 μM
EDTA; 0.1% gelatin.)
Twenty-five microliters of cocktail (Table VIII) were dispensed to each of seven reaction tubes. The genomic

DNA samples prepared from transformed lymphoblasts were from six anonymous individuals and are designated Hul-6. The genomic DNA samples were obtained from Drs. John Gilbert and Allen Roses of Duke Medical Center, Durham, NC. Each genomic DNA sample was prepared by adding 100 ng DNA (2-3 μl) to 25 μl H2O, heating in a boiling water bath for 1 min, and placing on ice. For each amplification reaction, 25 μl DNA was added to the reaction cocktail. Also, a blank reaction was prepared by adding 25 μl H2O to a tube containing reaction cocktail. The reactions were overlayed with a drop of mineral oil. Temperature cycling was performed in a DNA Thermal Cycler according to the following program: an initial 4 min incubation at 93°C; 30 cycles of 1 min at 93°C; 30 sec at 35°C; 2 min 10 sec ramp to 72°C; 2 min at 72°C; followed by a final 5 min incubation at 72°C. After transferring to fresh tubes, 50 μl 5 M ammonium acetate and 250 μl ethanol were added to each sample. Following a 2 hour incubation at -20°C, each DNA sample was collected by centrifugation, dried, and dissolved in 20 μl 10 mM Tris-HCl, pH 8.0; 1 mM EDTA.
Two microliters of each sample were electrophoresed on a 1.4% agarose gel (8.3-cm x 6 cm) in TAE buffer (40 mM Tris-acetate, pH 7.8; 5 mM sodium acetate; 1 mM ESTA) at 50 V for 160 min. After staining with ethidium, the gel was photographed using ultraviolet illumination. The results in Figure 6 show that samples Hul and Hu2 have a prominent band at approximately 1.3 kb that is not present in the four other samples. Thus, amplification using the 10 nucleotide primer AP9 was able to detect a genetic polymorphism that can be used to distinguish human DNA samples.

EXAMPLE 8 Ouantitation of PCR Products In Example 3, the process of this invention was used to genetically map a polymorphism. This was accomplished by determining the parental pattern of inheritance of the polymorphism in several segregating individuals. As practiced in Example 3, the investigator is unable to distinguish individuals heterozygous for a marker from individuals homozygous for the same marker, and the polymorphism is scored as being dominant. A heterozygous individual contains two different copies (alleles) of a particular DNA segment at a position (locus) in the genome. A homozygous individual will contain two identical alleles at a locus. In several applications (e.g., quantitative trait mapping) it is necessary to be able to distinguish heterozygous individuals. In the process of the present invention, it is expected that individuals inheriting two copies of a single allele will have two times the amount of amplified product as an individual inheriting only one copy of the same allele. To investigate whether heterozygotes could be distinguished from homozygotes by quantitating the results of the assay, individuals were chosen which were known to be homozygous for Bonus, heterozygous for both Bonus and PI81762 or homozygous for PI81762 DNA segments for the chromosomal region containing the band A polymorphism. These individuals were chosen on the basis of the genotype of flanking RFLP markers (see Example 3 and Table 3) . The same gels presented in Example 3 were analyzed by densitometry to determine the amount of amplified product corresponding to band A (see legend to Figure 7) . Panel A of Figure 7 represents a scan of individual 30 (see Example 3) homozygous for the PI81762 allele. Panel B of Figure 7 represents a scan of

individual 9 (see Example 3) heterozygous for Bonus and PI81762 alleles. Panel C of Figure 7 represents a scan of individual 57 (see Example 3) homozygous for the Bonus allele. Peaks corresponding to the band A polymorphism are labeled. The densitometry shows that individuals homozygous for PI81762 alleles contain twice the amount of DNA in the band A polymorphism than individuals which are heterozygous for PI81762 and Bonus. Individuals homozygous for the Bonus alleles do not contain any DNA corresponding to band A. This example shows that the products of amplification can be quantitated to identify heterozygous individuals and reveal a co-dominant polymorphism. This will have utility in procedures where it is necessary to distinguish heterozygotes from the corresponding homozygote.
Photographs of the gel separations shown in Figure 2 were digitized using a Cohu Monochrome CCD camera (model #4815-5000, Cohu Inc., San Diego, CA) attached to a Macintosh Ilex computer (Apple Computer Corp., Cupertino, CA) . The analog data was converted to digital input through a QuickCapture card (Data Translations Inc., Marlboro, MA). The individual lanes were scanned for quantitation with the Scan Analysis program (Version 2.11, Biosoft Inc., Milltown, N.J.). X-axis values correspond to electrophoretic distance, and Y-axis values correspond to peak intensity.

Claims (19)

Ci MS What is claimed is:

1. A process for distinguishing nucleic acids on the basis of nucleotide differences in random segments of the nucleic acids comprising:
(a) separately performing an extension reaction on each of at least two nucleic acids, said reaction comprising:
(i) contacting the nucleic acids with at least one oligonucleotide primer of greater than 7 nucleotides under conditions such that for at least one nucleic acid an extension product of at least one primer is synthesized; and
(b) comparing the results of the separately performed extension reactions for differences .

2. The process of Claim 1, after step (i) and before step (b) , comprising the additional steps of (ii) dissociating the extension product from its complement; and (iii) amplifying the random nucleic acid segment by contacting the dissociated extension product with a primer of step (i) under conditions such that an amplification extension product is synthesized using the dissociated extension product as a template.

3. The process of Claim 2 wherein the steps are performed at least twice.

4. The process of Claim 1 or 2 using a nucleic acid polymerase and nucleoside triphosphate substrates or their analogues and mixtures thereof .

5. The process of Claim 1 or 2 wherein one primer is employed.

6. The process of Claim 1 or 2 wherein the primer is from 9 to 10 nucleotides in length.

7. The process of Claim 1 or 2 wherein at least one primer is biotinylated.

8. The process of Claim 1 or 2 wherein the nucleic acids are from different individuals.

9. A process according to Claim 4, wherein the nucleic acid polymerase is a DNA polymerase and the nucleoside triphosphate substrates are deoxyribonucleoside triphosphate substrates.

10. A process according to Claim 9, wherein the DNA polymerase is a thermostable polymerase.

11. A process according to Claim 10, wherein the DNA polymerase is Taq polymerase.

12. The process of Claim 1 or 2, wherein the comparison is through a size fractionation medium.

13. A process according to Claim 12, wherein the comparison is performed by electrophoresis through a polyacrylamide gel matrix or agarose gel matrix.

14. The process of Claim 1 or 2, wherein the comparison is through restriction fragment length polymorphism analysis.

15. The process of Claim 1 or 2, wherein the comparison is through nucleotide sequence determination.

16. The process of Claim 1 or 2, wherein the nucleic acid source is selected from the group consisting of plant, animal and microbes.

17. The process of Claim 1 or 2 wherein the nucleic acid source is human.

18. The process of Claim 1 or 2 wherein a difference in the extension product is used as a marker to construct a genetic map.

19. The process of Claim 1 or 2 wherein a difference in the extension product is used as a marker to distinguish or identify individuals.

AU77820/91A
1990-03-14
1991-02-12
A process for distinguishing nucleic acids on the basis of nucleotide differences

Ceased

AU639565B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US494258

1990-03-14

US07/494,258

US5126239A
(en)

1990-03-14
1990-03-14
Process for detecting polymorphisms on the basis of nucleotide differences

Publications (2)

Publication Number
Publication Date

AU7782091A
true

AU7782091A
(en)

1991-10-10

AU639565B2

AU639565B2
(en)

1993-07-29

Family
ID=23963743
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU77820/91A
Ceased

AU639565B2
(en)

1990-03-14
1991-02-12
A process for distinguishing nucleic acids on the basis of nucleotide differences

Country Status (17)

Country
Link

US
(1)

US5126239A
(en)

EP
(1)

EP0520039B1
(en)

JP
(1)

JP2818486B2
(en)

AT
(1)

ATE115634T1
(en)

AU
(1)

AU639565B2
(en)

BR
(1)

BR9106151A
(en)

CA
(1)

CA2078132C
(en)

DE
(1)

DE69105959T2
(en)

DK
(1)

DK0520039T3
(en)

ES
(1)

ES2065684T3
(en)

FI
(1)

FI924049A0
(en)

IL
(1)

IL97503A
(en)

NO
(1)

NO304655B1
(en)

NZ
(1)

NZ237396A
(en)

PL
(1)

PL166895B1
(en)

WO
(1)

WO1991014001A2
(en)

ZA
(1)

ZA911891B
(en)

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

WO1994024307A1
(en)

1993-04-16
1994-10-27
Forbio Pty. Ltd.
Method of random amplification of polymorphic dna

Families Citing this family (100)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US5595870A
(en)

1989-02-17
1997-01-21
The Trustees Of Columbia University In The City Of New York
Identifying nucleic acids by restriction digestion and hybridization with random or pseudorandom oligonucleotides

US5547839A
(en)

1989-06-07
1996-08-20
Affymax Technologies N.V.
Sequencing of surface immobilized polymers utilizing microflourescence detection

JPH06500471A
(en)

1990-08-24
1994-01-20
ザ・ユニバーシティ・オブ・テネシー・リサーチ・コーポレーション

DNA amplification fingerprinting

US6074818A
(en)

1990-08-24
2000-06-13
The University Of Tennessee Research Corporation
Fingerprinting of nucleic acids, products and methods

WO1992004458A1
(en)

1990-09-11
1992-03-19
The Brookdale Hospital Medical Center
Drug resistance screening method

WO1992007095A1
(en)

1990-10-15
1992-04-30
Stratagene
Arbitrarily primed polymerase chain reaction method for fingerprinting genomes

US5635354A
(en)

1991-01-09
1997-06-03
Institut National De La Sante Et De La Recherche Medicale (Inserm)
Method for describing the repertoires of antibodies (Ab) and of T-cell receptors (TcR) of an individual’s immune system

US5401630A
(en)

1991-05-03
1995-03-28
The United States Of America As Represented By The Secretary Of Agriculture
Species-specific DNA-DNA hybridization probe prepared using chromosome size DNA

CA2077135A1
(en)

1991-08-30
1993-03-01
Joh-E Ikeda
A method of dna amplification

US7026115B1
(en)

1991-09-24
2006-04-11
Keygene N.V.
Selective restriction fragment amplification: fingerprinting

DK0969102T3
(en)

1991-09-24
2008-05-13
Keygene Nv

Primers, kits and sets of restriction fragments used in selective restriction fragment amplification

US20100267023A1
(en)

1992-09-24
2010-10-21
Keygene N.V.
Selective restriction fragment amplification: fingerprinting

US5665544A
(en)

1992-05-27
1997-09-09
Amersham International Plc
RNA fingerprinting to determine RNA population differences

US5340728A
(en)

1992-12-09
1994-08-23
E. I. Du Pont De Nemours And Company
Method for amplification of targeted segments of nucleic acid using nested polymerase chain reaction

US5962221A
(en)

1993-01-19
1999-10-05
Univ Tennessee Res Corp
Oligonucleotide constructs and methods for the generation of sequence signatures from nucleic acids

AU1682595A
(en)

1994-01-21
1995-08-08
North Carolina State University
Methods for within family selection in woody perennials using genetic markers

WO1995021269A1
(en)

1994-02-04
1995-08-10
Perlin Mark K
Method and apparatus for analyzing genetic material

US6037127A
(en)

1994-03-31
2000-03-14
E. I. Du Pont De Nemours And Company
Method for detection of non-denatured nucleic acid fragments

US5552278A
(en)

1994-04-04
1996-09-03
Spectragen, Inc.
DNA sequencing by stepwise ligation and cleavage

US5714330A
(en)

1994-04-04
1998-02-03
Lynx Therapeutics, Inc.
DNA sequencing by stepwise ligation and cleavage

US5831065A
(en)

1994-04-04
1998-11-03
Lynx Therapeutics, Inc.
Kits for DNA sequencing by stepwise ligation and cleavage

US5547861A
(en)

1994-04-18
1996-08-20
Becton, Dickinson And Company
Detection of nucleic acid amplification

US5585238A
(en)

1994-04-25
1996-12-17
Ciba-Geigy Corporation
Detection of fungal pathogens using the polymerase chain reaction

US5660981A
(en)

1994-06-06
1997-08-26
E. I. Du Pont De Nemours And Company
Selection of diagnostic genetic markers in microorganisms and use of a specific marker for detection of salmonella

USRE43097E1
(en)

1994-10-13
2012-01-10
Illumina, Inc.
Massively parallel signature sequencing by ligation of encoded adaptors

US6013445A
(en)

1996-06-06
2000-01-11
Lynx Therapeutics, Inc.
Massively parallel signature sequencing by ligation of encoded adaptors

AU704660B2
(en)

1994-11-28
1999-04-29
E.I. Du Pont De Nemours And Company
Compound microsatellite primers for the detection of genetic polymorphisms

ES2097701B1
(en)

1995-02-09
1997-11-16
Consejo Superior Investigacion

PROCEDURE FOR OBTAINING SPECIFIC STYLE OR SPECIES PROBES.

JPH09149799A
(en)

1995-11-30
1997-06-10
Hitachi Ltd
Analysis or detection of nucleic acid and analyser or inspection device of nucleic acid

US5670325A
(en)

1996-08-14
1997-09-23
Exact Laboratories, Inc.
Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample

US5741650A
(en)

1996-01-30
1998-04-21
Exact Laboratories, Inc.
Methods for detecting colon cancer from stool samples

US5747257A
(en)

1996-02-29
1998-05-05
E. I. Du Pont De Nemours And Company
Genetic markers and methods for the detection of escherichia coli serotype-0157:H7

ATE366418T1
(en)

1996-04-25
2007-07-15
Bioarray Solutions Ltd

LIGHT-REGULATED, ELECTROKINETIC COMPOSITION OF PARTICLES ON SURFACES

US5811239A
(en)

1996-05-13
1998-09-22
Frayne Consultants
Method for single base-pair DNA sequence variation detection

US6203993B1
(en)

1996-08-14
2001-03-20
Exact Science Corp.
Methods for the detection of nucleic acids

US5928870A
(en)

1997-06-16
1999-07-27
Exact Laboratories, Inc.
Methods for the detection of loss of heterozygosity

US6020137A
(en)

1996-08-14
2000-02-01
Exact Laboratories, Inc.
Methods for the detection of loss of heterozygosity

US6146828A
(en)

1996-08-14
2000-11-14
Exact Laboratories, Inc.
Methods for detecting differences in RNA expression levels and uses therefor

US6300077B1
(en)

1996-08-14
2001-10-09
Exact Sciences Corporation
Methods for the detection of nucleic acids

US5952178A
(en)

1996-08-14
1999-09-14
Exact Laboratories
Methods for disease diagnosis from stool samples

US6100029A
(en)

1996-08-14
2000-08-08
Exact Laboratories, Inc.
Methods for the detection of chromosomal aberrations

US5814453A
(en)

1996-10-15
1998-09-29
Novartis Finance Corporation
Detection of fungal pathogens using the polymerase chain reaction

US5800997A
(en)

1996-11-01
1998-09-01
Novartis Finance Corporation
Detection of maize fungal pathogens using the polymerase chain reaction

US5922538A
(en)

1996-11-08
1999-07-13
E.I. Du Pont De Nemours And Company
Genetic markers and methods for the detection of Listeria monocytogenes and Listeria spp

US6268136B1
(en)

1997-06-16
2001-07-31
Exact Science Corporation
Methods for stool sample preparation

US6406857B1
(en)

1997-06-16
2002-06-18
Exact Sciences Corporation
Methods for stool sample preparation

US5827695A
(en)

1997-08-04
1998-10-27
Novartis Finance Corporation
Detection of wheat fungal pathogens using the polymerase chain reaction

US6173525B1
(en)

1997-09-19
2001-01-16
Cantharellus Ab
Chanterelle mycelium

US20020064792A1
(en)

1997-11-13
2002-05-30
Lincoln Stephen E.
Database for storage and analysis of full-length sequences

WO1999039001A2
(en)

1998-02-02
1999-08-05
Amersham Pharmacia Biotech Ab
Nucleic acid analysis method

US7078224B1
(en)

1999-05-14
2006-07-18
Promega Corporation
Cell concentration and lysate clearance using paramagnetic particles

US8337753B2
(en)

1998-05-01
2012-12-25
Gen-Probe Incorporated
Temperature-controlled incubator having a receptacle mixing mechanism

EP2316570A3
(en)

1998-05-01
2011-07-27
Gen-Probe Incorporated
Automated diagnostic analyzer and method

US6284466B1
(en)

1998-09-18
2001-09-04
The Board Of Regents Of University Of Nebraska
Method of detecting genetic polymorphisms using over represented sequences

US6703228B1
(en)

1998-09-25
2004-03-09
Massachusetts Institute Of Technology
Methods and products related to genotyping and DNA analysis

EP1001037A3
(en)

1998-09-28
2003-10-01
Whitehead Institute For Biomedical Research
Pre-selection and isolation of single nucleotide polymorphisms

CA2352534A1
(en)

1998-12-08
2000-06-15
Children’s Hospital And Regional Medical Center
Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains

US6503718B2
(en)

1999-01-10
2003-01-07
Exact Sciences Corporation
Methods for detecting mutations using primer extension for detecting disease

US6280947B1
(en)

1999-08-11
2001-08-28
Exact Sciences Corporation
Methods for detecting nucleotide insertion or deletion using primer extension

ES2269102T3
(en)

1999-02-25
2007-04-01
Exact Sciences Corporation

PROCEDURES TO PRESERVE THE INTEGRITY OF DNA.

FR2792000B1
(en)

1999-04-08
2003-04-11
Centre Nat Rech Scient

METHOD FOR MAPPING A DNA MOLECULE COMPRISING AN AD INFINITUM AMPLIFICATION STEP

ATE331811T1
(en)

1999-04-09
2006-07-15
Exact Sciences Corp

METHOD FOR DETECTING NUCLEIC ACIDS INdicative of CANCER

US6849403B1
(en)

1999-09-08
2005-02-01
Exact Sciences Corporation
Apparatus and method for drug screening

US6586177B1
(en)

1999-09-08
2003-07-01
Exact Sciences Corporation
Methods for disease detection

US6919174B1
(en)

1999-12-07
2005-07-19
Exact Sciences Corporation
Methods for disease detection

AU4714201A
(en)

1999-12-07
2001-06-18
Exact Sciences Corporation
Supracolonic aerodigestive neoplasm detection

US6242191B1
(en)

1999-12-30
2001-06-05
The Ohio State University Research Foundation
Methods for assessing the beef characteristics of live cattle

AU6052001A
(en)

2000-03-29
2001-10-08
Ct For The Applic Of Molecular
Methods for genotyping by hybridization analysis

US9709559B2
(en)

2000-06-21
2017-07-18
Bioarray Solutions, Ltd.
Multianalyte molecular analysis using application-specific random particle arrays

WO2001098765A1
(en)

2000-06-21
2001-12-27
Bioarray Solutions, Ltd.
Multianalyte molecular analysis

US7695901B2
(en)

2000-07-26
2010-04-13
North Carolina State University
Identification of poinsettia cultivars

EP1207209A3
(en)

2000-11-09
2002-09-11
Agilent Technologies, Inc. (a Delaware corporation)
Methods using arrays for detection of single nucleotide polymorphisms

US6428964B1
(en)

2001-03-15
2002-08-06
Exact Sciences Corporation
Method for alteration detection

US7262063B2
(en)

2001-06-21
2007-08-28
Bio Array Solutions, Ltd.
Directed assembly of functional heterostructures

NZ532947A
(en)

2001-10-15
2006-01-27
Bioarray Solutions Ltd
Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection

EP1461432A2
(en)

2001-12-10
2004-09-29
Iowa State University Research Foundation, Inc.
Nucleic acids related to plant retroelements

AU2003213107A1
(en)

2002-02-15
2003-09-09
Exact Sciences Corporation
Methods for analysis of molecular events

US7157228B2
(en)

2002-09-09
2007-01-02
Bioarray Solutions Ltd.
Genetic analysis and authentication

AU2003298655A1
(en)

2002-11-15
2004-06-15
Bioarray Solutions, Ltd.
Analysis, secure access to, and transmission of array images

US20060068036A1
(en)

2002-12-31
2006-03-30
National Yang-Ming University
Extract of Dioscorea sp. and the medical uses thereof

US20040259101A1
(en)

2003-06-20
2004-12-23
Shuber Anthony P.
Methods for disease screening

US7927796B2
(en)

2003-09-18
2011-04-19
Bioarray Solutions, Ltd.
Number coding for identification of subtypes of coded types of solid phase carriers

EP1664722B1
(en)

2003-09-22
2011-11-02
Bioarray Solutions Ltd
Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules

US7563569B2
(en)

2003-10-28
2009-07-21
Michael Seul
Optimization of gene expression analysis using immobilized capture probes

CA2544202C
(en)

2003-10-29
2012-07-24
Bioarray Solutions Ltd.
Multiplexed nucleic acid analysis by fragmentation of double-stranded dna

US20080241827A1
(en)

2004-05-10
2008-10-02
Exact Sciences Corporation
Methods For Detecting A Mutant Nucleic Acid

US20080124714A1
(en)

2004-05-14
2008-05-29
Exact Sciences Corporation
Method for Stabilizing Biological Samples for Nucleic Acid Analysis

US7848889B2
(en)

2004-08-02
2010-12-07
Bioarray Solutions, Ltd.
Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification

EP1623996A1
(en)

2004-08-06
2006-02-08
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Improved method of selecting a desired protein from a library

WO2006026654A2
(en)

2004-08-27
2006-03-09
Exact Sciences Corporation
Method for detecting a recombinant event

WO2006047787A2
(en)

2004-10-27
2006-05-04
Exact Sciences Corporation
Method for monitoring disease progression or recurrence

WO2007044071A2
(en)

2005-04-21
2007-04-19
Exact Sciences Corporation
Analysis of heterogeneous nucleic acid samples

US8486629B2
(en)

2005-06-01
2013-07-16
Bioarray Solutions, Ltd.
Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation

CA2613094A1
(en)

2005-07-01
2007-01-11
Promega Corporation
Network of buoyant particles for biomolecule purification

US8030034B2
(en)

2005-12-09
2011-10-04
Promega Corporation
Nucleic acid purification with a binding matrix

US20110086343A1
(en)

2006-03-10
2011-04-14
Hemant Jyotiswarup Purohit
Method for the screening of bacterial isolates

US8481267B2
(en)

2009-08-21
2013-07-09
E. I. Du Pont De Nemours And Company
Genetic fingerprinting and identification method

US8222397B2
(en)

2009-08-28
2012-07-17
Promega Corporation
Methods of optimal purification of nucleic acids and kit for use in performing such methods

US8039613B2
(en)

2009-08-28
2011-10-18
Promega Corporation
Methods of purifying a nucleic acid and formulation and kit for use in performing such methods

WO2013016129A1
(en)

2011-07-25
2013-01-31
E. I. Du Pont De Nemours And Company
Method to amplify nucleic acids to generate fluorescence labeled fragments of conserved and arbitrary products

Family Cites Families (8)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4683202A
(en)

1985-03-28
1987-07-28
Cetus Corporation
Process for amplifying nucleic acid sequences

US4683195A
(en)

1986-01-30
1987-07-28
Cetus Corporation
Process for amplifying, detecting, and/or-cloning nucleic acid sequences

US4851331A
(en)

1986-05-16
1989-07-25
Allied Corporation
Method and kit for polynucleotide assay including primer-dependant DNA polymerase

EP0317239A3
(en)

1987-11-13
1990-01-17
Native Plants Incorporated
Method and device for improved restriction fragment length polymorphism analysis

AU632760B2
(en)

1988-07-26
1993-01-14
Genelabs Technologies, Inc.
Rna and dna amplification techniques

US4879214A
(en)

1988-11-15
1989-11-07
E. I. Du Pont De Nemours And Company
Differentiation of nucleic acid segments on the basis of nucleotide differences

DE69033179T3
(en)

1989-02-13
2005-01-27
Geneco Pty. Ltd.

EVIDENCE OF A NUCLEIC ACID SEQUENCE OR A CHANGE IN IT

US5043272A
(en)

1989-04-27
1991-08-27
Life Technologies, Incorporated
Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers

1990

1990-03-14
US
US07/494,258
patent/US5126239A/en
not_active
Expired – Lifetime

1991

1991-02-12
WO
PCT/US1991/000841
patent/WO1991014001A2/en
active
IP Right Grant

1991-02-12
AT
AT91908846T
patent/ATE115634T1/en
not_active
IP Right Cessation

1991-02-12
BR
BR919106151A
patent/BR9106151A/en
not_active
IP Right Cessation

1991-02-12
EP
EP91908846A
patent/EP0520039B1/en
not_active
Expired – Lifetime

1991-02-12
CA
CA002078132A
patent/CA2078132C/en
not_active
Expired – Lifetime

1991-02-12
ES
ES91908846T
patent/ES2065684T3/en
not_active
Expired – Lifetime

1991-02-12
JP
JP3508563A
patent/JP2818486B2/en
not_active
Expired – Fee Related

1991-02-12
DK
DK91908846.8T
patent/DK0520039T3/en
active

1991-02-12
AU
AU77820/91A
patent/AU639565B2/en
not_active
Ceased

1991-02-12
PL
PL91293188A
patent/PL166895B1/en
not_active
IP Right Cessation

1991-02-12
DE
DE69105959T
patent/DE69105959T2/en
not_active
Expired – Fee Related

1991-03-11
IL
IL9750391A
patent/IL97503A/en
not_active
IP Right Cessation

1991-03-12
NZ
NZ237396A
patent/NZ237396A/en
unknown

1991-03-14
ZA
ZA911891A
patent/ZA911891B/en
unknown

1992

1992-09-10
FI
FI924049A
patent/FI924049A0/en
not_active
Application Discontinuation

1992-09-11
NO
NO922800A
patent/NO304655B1/en
not_active
IP Right Cessation

Cited By (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

WO1994024307A1
(en)

1993-04-16
1994-10-27
Forbio Pty. Ltd.
Method of random amplification of polymorphic dna

US5759821A
(en)

1993-04-16
1998-06-02
F B Investments Pty Ltd
Method of random amplification of polymorphic DNA

Also Published As

Publication number
Publication date

EP0520039B1
(en)

1994-12-14

JPH05505528A
(en)

1993-08-19

NO923544D0
(en)

1992-09-11

ES2065684T3
(en)

1995-02-16

CA2078132A1
(en)

1991-09-15

EP0520039A1
(en)

1992-12-30

JP2818486B2
(en)

1998-10-30

US5126239A
(en)

1992-06-30

AU639565B2
(en)

1993-07-29

FI924049A
(en)

1992-09-10

PL293188A1
(en)

1992-11-02

IL97503A0
(en)

1992-06-21

BR9106151A
(en)

1993-03-09

DK0520039T3
(en)

1995-02-20

IL97503A
(en)

1995-05-26

DE69105959T2
(en)

1995-05-18

WO1991014001A2
(en)

1991-09-19

CA2078132C
(en)

1999-08-31

ZA911891B
(en)

1992-11-25

NO304655B1
(en)

1999-01-25

PL166895B1
(en)

1995-06-30

WO1991014001A3
(en)

1991-10-31

DE69105959D1
(en)

1995-01-26

ATE115634T1
(en)

1994-12-15

NO923544L
(en)

1992-09-11

NZ237396A
(en)

1993-08-26

FI924049A0
(en)

1992-09-10

Información de contacto